January 29, 2015 2:37 PM ET

Life Sciences Tools and Services

Company Overview of Innopsys SA

Company Overview

Innopsys SA develops and markets instruments and associated software for biology laboratories. It offers 2-colour fluorescence scanners for applications, such as HD CGH arrays, HD microarrays, and protein nanoarrays; InnoScan 710 for routine microarray reading; InnoScan 900 for reading current and future high-density microarrays; auto loaders; and Mapix, a data acquisition and analysis software for microarray images. The company offers its products for functional genomics and proteomics applications. The company markets its products through a network of distributors in France and internationally, and through its subsidiary in the United States. Innopsys SA was founded in 1999 and is based in...

Parc d'Activités Activestre

Carbonne,  31 390


Founded in 1999


33 5 61 97 19 74


33 5 61 97 19 75

Key Executives for Innopsys SA

Chief Executive Officer and Financial Director
Sales Director and Executive Director
Compensation as of Fiscal Year 2014.

Innopsys SA Key Developments

Scienion AG and Innopsys SA Agree on Joint Product Offering for Reverse Phase Protein Arrays

Scienion AG and Innopsys SA announced cooperation agreement on a seamless integration of its microarray production and detection equipment. Combining technologies of both companies will benefit customers for a broad range of applications. A good example is "reverse phase protein array". RPPA is a high-throughput antibody-based technique developed for functional proteomics studies to evaluate protein activities in biological networks. This is useful in identifying drug selectivity, classifying tumors, predicting responses to target therapies, and many more. Lysates from cultured cells or patient tissue samples are typically deposited and incubated on nitrocellulose membranes. Scienion's sciFLEXARRAYER technology can precisely and gently print lysates on nitrocellulose coated glass slides without damage to the surface. Innopsys InnoScan® 710-IR near infrared scanner is the only product that allows for an IR detection readout of these arrays. It combines a 3µm per pixel resolution with 670 nm and 785 nm excitation lasers, a spectral range where the auto-fluorescence of nitrocellulose that is typically present in the visible range is significantly decreased. This product combination will significantly improve signal to noise ratios. Systems will be offered as full out-of-the-box solutions, where equipment and software have been configured to execute RPPA assays from A to Z. This will lower the barrier of entry, allowing more researchers to experiment with RPPA.

Similar Private Companies By Industry

Company Name Region
FORENAP Pharma EURL Europe
BodyCap SAS Europe
Metabolys SAS Europe
Creapharm SAS Europe
Tereo International SARL Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Innopsys SA, please visit www.innopsys.fr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.